Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 5 (2008), Issue 3 (March)

1. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
   Nat Clin Pract Rheumatol, 4(3): 128-35. [Abstract] [Full-text]
2. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
   Expert Opin Investig Drugs, 17(3): 349-59. [Abstract] [Full-text]
3. The fellowship of the RING: the RING-B-box linker region interacts with the RING in TRIM21/Ro52, contains a native autoantigenic epitope in Sjögren syndrome, and is an integral and conserved region in TRIM proteins.
   J Mol Biol, 377(2): 431-49. [Abstract] [Full-text]
4. Amygdala volume in patients receiving chronic corticosteroid therapy.
   Biol Psychiatry, 63(7): 705-9. [Abstract] [Full-text]
5. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
   Ann Rheum Dis, 67(4): 563-6. [Abstract] [Full-text]
6. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy.
   Ann Rheum Dis, 67(4): 547-54. [Abstract] [Full-text]
7. Granuloma annulare induced by anti-tumour necrosis factor therapy.
   Ann Rheum Dis, 67(4): 567-70. [Abstract] [Full-text]
8. Co-activation of synovial fibroblasts by laminin-111 and transforming growth factor-beta induces expression of matrix metalloproteinases 3 and 10 independently of nuclear factor-kappaB.
   Ann Rheum Dis, 67(4): 559-62. [Abstract] [Full-text]
9. Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic.
   Ann Rheum Dis, 67(4): 462-5. [Abstract] [Full-text]
10. The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis.
    Ann Rheum Dis, 67(4): 518-23. [Abstract] [Full-text]
11. A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.
    Ann Rheum Dis, 67(4): 478-84. [Abstract] [Full-text]
12. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women.
    Ann Rheum Dis, 67(4): 530-5. [Abstract] [Full-text]
13. The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands.
    Ann Rheum Dis, 67(4): 524-9. [Abstract] [Full-text]
14. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.
    Ann Rheum Dis, 67(4): 466-70. [Abstract] [Full-text]
15. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
    Ann Rheum Dis, 67(4): 542-6. [Abstract] [Full-text]
16. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.
    Lancet, 371(9617): 998-1006. [Abstract] [Full-text]
17. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.
    Lancet, 371(9617): 987-97. [Abstract] [Full-text]
18. Mycoplasma fermentans glycolipid-antigen as a pathogen of rheumatoid arthritis.
    Biochem Biophys Res Commun, 369(2): 561-6. [Abstract] [Full-text]
19. Lymphocyte-derived cytokines in inflammatory arthritis.
    Autoimmunity, 41(3): 230-8. [Abstract] [Full-text]
20. Review: Immune cells and mediators of inflammatory arthritis.
    Autoimmunity, 41(3): 224-9. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.